Medical network - on March 30, 2016 is the "policy" of TCM industry, year countries successively issued a series of blockbuster files: the "healthy China 2030" planning outline, the strategic plan for development of Chinese medicine (2016-2030) ", "" much starker choices-and graver consequences-in planning and development of Chinese medicine", "China's traditional Chinese medicine", the white paper, etc., and formally launched on December 25, the first comprehensive, system embodies the fundamental law, characteristics and rules of Chinese medicine of traditional Chinese medicine of the People's Republic of China law. These laws and regulations enacted aims to promote the revitalization of traditional Chinese medicine and traditional Chinese medicine will rise for the national development strategy, make the system more sound development of Chinese medicine, Chinese medicine industry development is faster, more inclusive open development of Chinese medicine. 

 

The birth of the relevant laws and regulations of traditional Chinese medicine and its long-term layout, is inseparable from the research on the present situation of development of Chinese medicine, however, all the year round to field of traditional Chinese medicine authority statistics missing has been in-depth study of traditional Chinese medicine insuperable obstacles. Today, let us with the analysis of China's pharmaceutical industry information center hospital prescription system (RAS), covering more than 60 major hospital in Shanghai this doctor first hand the authority of the original prescription data platform to earnestly study the status quo of medication of proprietary Chinese medicine at present in Shanghai. 

 

1, proprietary Chinese medicine usage analysis 

 

 

Data sources: China's pharmaceutical industry information center hospital prescription analysis system (RAS) 

 

According to China's pharmaceutical industry information center hospital prescription analysis system (RAS) 2015 q4-2016 q3 samples of Shanghai hospital prescription data statistics (see figure 1 and figure 2) : basic-level hospital proprietary Chinese medicine dosage proportion with western medicine, close to 50% (with proprietary Chinese medicine oral preparations, injection, 84.4% and 9.4%, among them 100%), the higher the level of hospital proprietary Chinese medicine proportion is lower, so the basic-level hospitals at present is still the focus of the proprietary Chinese medicine sales terminals, with the establishment of the grading system of diagnosis and treatment in the future, high quality medical resources sinking, visit patients and patients with chronic diseases increase in the number, grass-roots hospital proprietary Chinese medicine dosage will rise. But q3 q4 2015-2015, the Chinese medicine and traditional Chinese medicine (TCM) injections depression effects such as raw material inspection, the dosage of the proprietary Chinese medicine in different level hospitals in Shanghai general all have varying degrees of decline, the dosage of relatively high, and serious secondary hospitals fall: one, two, tertiary hospital 2016 q3mat growth of 6.4%, 10.2%, 10.2% respectively. To 2015 q4 drug varieties, Shanghai of 1106 on using proprietary Chinese medicine varieties, in addition to 84 does not appear in q3 2016 prescription data of China and foreign countries, only 71 varieties prescription number increased slightly, the rest 951 varieties were negative. Visible, proprietary Chinese medicine in the hospital the dosage of the terminal and clinical safety recognition is experiencing the shrinking and trial, as countries a series of policy whether the situation is expected to break, landing remains to be seen. 

 

2, proprietary Chinese medicine use rate 

 

Table 1 use proprietary Chinese medicine in the top 10 departments proprietary Chinese medicine usage (number %) 

 

Data sources: China's pharmaceutical industry information center hospital prescription analysis system (RAS) 

 

Q4 2015-2016 q3 proprietary Chinese medicine prescription sampling 6.2774 million pieces, value of 995.8054 million yuan. Use proprietary Chinese medicine in the top 10 departments including medicine usage (see table 1). Proprietary Chinese medicine to use the highest frequency of three outpatient department general internal medicine, Chinese medicine internal medicine outpatient service, infantile general medicine outpatient proprietary Chinese medicine utilization rate are 20.3%, 26.5% and 20.3% respectively, the top 10 highest utilization rate of orthopaedic outpatient proprietary Chinese medicine, department of dermatology general outpatient proprietary Chinese medicine utilization minimum. Proprietary Chinese medicine in the clinical department of outpatient emergency care and widely distributed include 138 inpatient department, it is on the clinical treatment, has been generally recognized by the department, including western medicine. Especially in cardiovascular disease, the treatment of bone related diseases, respiratory diseases by the doctor's extensive trust and use, such as a large number of used in coronary heart disease, high blood pressure, respiratory infections, bronchitis, joint pain, such as disease, involving patients of different ages up to the octogenarian old man a two-year-old child, so the quality control of proprietary Chinese medicine and drug safety in clinical controversial at present, need through the relevant laws and regulations to improve and standardize the quality standard and clinical safety evaluation system. 

 

3, proprietary Chinese medicine varieties distribution 

 

Table 2 samples of Shanghai hospital need traditional varieties 

 

Data sources: China's pharmaceutical industry information center hospital prescription analysis system (RAS) 

 

In medical insurance fees, hospital medicine proportion adjustment, standardized clinical pathway under the reform policies and measures, such as part of the hospital on the use of TCM injections and procurement varieties limit and cut, even stopped. Compared with TCM injections of prescriptions of the last few years, especially in this significant decline. But traditional varieties in the top 10 (see table 2), we still can see many consistent proven clinical curative effect of injection and the frequency of usage is still stay in the top 2-5, most of them for promoting blood circulation to remove blood stasis, pulse ShuLao proprietary Chinese medicine, as stroke, poliomyelitis, coronary heart disease, cerebral infarction treatment adjuvant, cooperate with western medicine have the effect of supplement each other. In addition, the biggest classified as proprietary Chinese medicine for oral administration, the overall account for more than 66.3% of proprietary Chinese medicine prescriptions of the hospital, community and even as high as 84.4%, one of the few in the prescription number at the stage of growth of 71 varieties, the fastest growing and most promising proprietary Chinese medicine, mostly oral preparations, such as effective oral liquid, naked flowers violet pearl particles, milk fights capsule, glandularstalk st.paulswortherb/common st.paulswort tong chuan capsule, etc., and because of its convenient taking and popular with the patients, combined with the policy, may be varieties of hospital in orally deserves more attention in the future.